Global Locations

3-Epi Empagliflozin (S)-Furanose



Chemical Properties of '3-Epi Empagliflozin (S)-Furanose'

CAT No. :

CS-O-14890
Parent API : Empagliflozin
CAS Registry No. : Not available
Category : Impurity Standards
Molecular Weight: 450.91
Molecular Formula : C₂₃H₂₇ClO₇
Controlled Substance : NO
Purity : >98%
Therapeutic : Anti-Diabetic
Synonyms : Not available
Application : Impurity in commercial preparation of Empagliflozin.
References : "Thomas; L,; et al,: Diabetes, Obesity, Metabol, 14; 94 (2012); Grempler; R,; et al,: Diabetes, Obesity, Metabol,; 14; 83 (2012),"
Custom Duty : Applicable
Documents:  View Sample COA   View Sample MSDS
Port of Loading : Canada
Expected Dispatch : 2-3 Weeks
Taxes : Not Applicable
Refund Policy : 30-days money back


More information about 3-Epi Empagliflozin (S)-Furanose


Empagliflozin, sold under the brand name Jardiance among others, is an antidiabetic medication used to improve glucose control in people with type 2 diabetes, used to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease, used to reduce the risk of death and hospitalization in people with heart failure and low ejection fraction, and used to reduce the risk of cardiovascular death and hospitalization for heart failure in adults. It can be prescribed instead of metformin and has benefits over sulfonylureas. It may be used together with other medications such as metformin or insulin. It is not recommended for type 1 diabetes. It is taken by mouth.

Common side effects include urinary tract infections, fungal infections of the groin, and joint pains. Rarer but more serious side effects include a skin infection of the groin called Fournier's gangrene and a form of diabetic ketoacidosis with normal blood sugar levels. Use in pregnancy and breastfeeding is not recommended. Use is not recommended in those with significant kidney disease, though it may help slow the progression of mild kidney problems. Empagliflozin is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2), and works by increasing sugar lost in the urine.

Empagliflozin was approved for medical use in the United States and in the European Union in 2014. It is on the World Health Organization's List of Essential Medicines. In 2019, it was the 146th most commonly prescribed medication in the United States, with more than 4\u00a0million prescriptions.



This page contains information about 3-Epi Empagliflozin (S)-Furanose , 3-Epi Empagliflozin (S)-Furanose cas, 3-Epi Empagliflozin (S)-Furanose synthesis, 3-Epi Empagliflozin (S)-Furanose suppliers

What is 3-Epi Empagliflozin (S)-Furanose ?
3-Epi Empagliflozin (S)-Furanose falls under Impurity Standards of Empagliflozin.Impurity in commercial preparation of Empagliflozin.
What is the CAS Number of 3-Epi Empagliflozin (S)-Furanose?
The CAS Number of 3-Epi Empagliflozin (S)-Furanose is Not available
Who are the suppliers of 3-Epi Empagliflozin (S)-Furanose?
CLEARSYNTH is a worldwide supplier of 3-Epi Empagliflozin (S)-Furanose

Related compounds of 3-Epi Empagliflozin (S)-Furanose

Looking for a discounted price or need more info for '3-Epi Empagliflozin (S)-Furanose (CS-O-14890)' ?

If you are looking for Bulk purchase, Discounted Price, etc. please share your email and the exact quantity you are looking for, our team will respond to you within 30 mins with all the required information.

Looking for a discounted price or need more info for '3-Epi Empagliflozin (S)-Furanose (CS-O-14890)' ?

If you are looking for Bulk purchase, Discounted Price, etc. please share your email and the exact quantity you are looking for, our team will respond to you within 30 mins with all the required information.